title: Symptomatic versus metabolic changes with pharmacotherapy of schizophrenia.
authors.forename: Joyce G
authors.initials: JG
authors.lastname: Small
authors.forename: Marietta H
authors.initials: MH
authors.lastname: Klapper
authors.forename: Frederick W
authors.initials: FW
authors.lastname: Malloy
authors.forename: Carla E
authors.initials: CE
authors.lastname: Medlock
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Kellams
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D020738:Leptin / Q000097:blood; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism*; D015430:Weight Gain
chemical_list: D014150:Antipsychotic Agents; D007328:Insulin; D020738:Leptin; D002784:Cholesterol